These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36072008)
1. Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer. Luo X; Tai J; Zhao Y; Zhao P; Sun D; Wang L Oncol Lett; 2022 Oct; 24(4):348. PubMed ID: 36072008 [TBL] [Abstract][Full Text] [Related]
2. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients. Gu L; Yao Y; Chen Z Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406 [TBL] [Abstract][Full Text] [Related]
3. Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients. Wan X; Hong Z; Mao Y; Di W Transl Cancer Res; 2020 Feb; 9(2):726-734. PubMed ID: 35117418 [TBL] [Abstract][Full Text] [Related]
4. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer. Wang D; Luo Y; Guo Y; Li G; Li F Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056 [TBL] [Abstract][Full Text] [Related]
5. The role of CXCL chemokine family in the development and progression of gastric cancer. Chen X; Chen R; Jin R; Huang Z Int J Clin Exp Pathol; 2020; 13(3):484-492. PubMed ID: 32269686 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma. Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S Front Oncol; 2020; 10():570736. PubMed ID: 33489879 [TBL] [Abstract][Full Text] [Related]
7. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer. Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873 [TBL] [Abstract][Full Text] [Related]
8. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia. Hao X; Gu M; Sun J; Cong L J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252 [TBL] [Abstract][Full Text] [Related]
9. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection. Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544 [TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer. Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929 [TBL] [Abstract][Full Text] [Related]
11. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer. Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer. Li X; Zhong Q; Luo D; Du Q; Liu W PLoS One; 2019; 14(4):e0214611. PubMed ID: 30973890 [TBL] [Abstract][Full Text] [Related]
13. Complementary action of CXCL1 and CXCL8 in pathogenesis of gastric carcinoma. Chen X; Jin R; Chen R; Huang Z Int J Clin Exp Pathol; 2018; 11(2):1036-1045. PubMed ID: 31938199 [TBL] [Abstract][Full Text] [Related]
14. SOX30 Overexpression Reflects Tumor Invasive Degree, Lymph Node Metastasis and Predicts Better Survival in Colorectal Cancer Patients: A Long-Term Follow-Up Cohort Study. Li C; Li P; Yu L; Sun Q; Gu B; Sun Y; Sun L Front Surg; 2022; 9():898952. PubMed ID: 35836594 [TBL] [Abstract][Full Text] [Related]
15. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer. Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623 [TBL] [Abstract][Full Text] [Related]
16. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways. Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353 [TBL] [Abstract][Full Text] [Related]
17. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis. Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034 [TBL] [Abstract][Full Text] [Related]
18. A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer. Chu Y; Li J; Zeng Z; Huang B; Zhao J; Liu Q; Wu H; Fu J; Zhang Y; Zhang Y; Cai J; Zeng F Front Oncol; 2020; 10():575422. PubMed ID: 33178604 [No Abstract] [Full Text] [Related]
19. CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Wei Y; Lin C; Li H; Xu Z; Wang J; Li R; Liu H; Zhang H; He H; Xu J Cancer Immunol Immunother; 2018 Feb; 67(2):261-269. PubMed ID: 29085997 [TBL] [Abstract][Full Text] [Related]
20. Potential of C-X-C motif chemokine ligand 1/8/10/12 as diagnostic and prognostic biomarkers in idiopathic pulmonary arterial hypertension. Li Z; Jiang J; Gao S Clin Respir J; 2021 Dec; 15(12):1302-1309. PubMed ID: 34260815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]